EGFR-IN-69

Modify Date: 2024-01-07 07:40:03

EGFR-IN-69 Structure
EGFR-IN-69 structure
Common Name EGFR-IN-69
CAS Number 2433837-65-9 Molecular Weight 658.64
Density N/A Boiling Point N/A
Molecular Formula C31H37Cl2N7O3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of EGFR-IN-69


EGFR-IN-69 (compound 17g) is a potent EGFR inhibitor, with IC50 values of 4.3, 6.6 and 25.6 nM against EGFRL858R/T790M/C797S, EGFRL858R/T790M, and EGFR19del/T790M/C797S, respectively. EGFR-IN-69 can be used for non-small-cell-lung-cancer (NSCLC) research[1].

 Names

Name EGFR-IN-69

 EGFR-IN-69 Biological Activity

Description EGFR-IN-69 (compound 17g) is a potent EGFR inhibitor, with IC50 values of 4.3, 6.6 and 25.6 nM against EGFRL858R/T790M/C797S, EGFRL858R/T790M, and EGFR19del/T790M/C797S, respectively. EGFR-IN-69 can be used for non-small-cell-lung-cancer (NSCLC) research[1].
Related Catalog
Target

EGFR L858R/T790M/C797S:4.3 ± 0.9 nM (IC50)

EGFRL858R/T790M:6.6 ± 0.8 nM (IC50)

EGFRdel19 T790M C797S:25.6 ± 7.5 nM (IC50)

EGFRWT:816.0 ± 82 nM (IC50)

References

[1]. Chen H, et al. Conformational Constrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine Derivatives as New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations. J Med Chem. 2022 May 12;65(9):6840-6858.

 Chemical & Physical Properties

Molecular Formula C31H37Cl2N7O3S
Molecular Weight 658.64